6505--Presolicitation/Sources Sought for Posluma for PET CT Imaging
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 16, is conducting a Sources Sought / Request for Information (RFI) for Posluma for PET CT Imaging services at the Central Arkansas Veterans Healthcare System (CAVHS) in Little Rock, AR. This market research aims to identify qualified contractors and determine the appropriateness of a small business set-aside for a future competitive, firm-fixed-price contract. Responses are due by May 22, 2026, at 10:00 am CST.
Purpose
This RFI seeks to gather information on contractor interest, capabilities, qualifications, compliance with the nonmanufacturer rule, and estimated industry pricing. The findings will inform the government's decision on potential small business set-asides and budgetary planning for the anticipated requirement.
Scope of Work
The successful contractor will be responsible for providing all resources necessary for the delivery of Posluma for PET CT imaging. This includes:
- Routine orders: Next-day delivery.
- Urgent/Emergent requests: Delivery within one (1) hour.
- Adherence to Department of Transportation (DOT) and Nuclear Regulatory Commission (NRC) radiation limits and transporting protocols.
- Compliance with 10 CFR Part 35 (NRC Medical Use of Byproduct Material) and 49 CFR Part 173 Subpart I (Class 7 Radioactive Materials).
- Contractor must be a licensed compounding pharmacy in good standing and obtain U.S. Food & Drug Administration (FDA) approval for radiopharmaceuticals.
- Services also include picking up White Blood Cell (WBC) scans within 1 hour and returning tagged blood within 3 hours.
Contract & Timeline
- Opportunity Type: Sources Sought / Request for Information (RFI). This is not a solicitation.
- Anticipated Contract Type: Firm Fixed Price.
- Anticipated Period of Performance: A base year (12 months) plus four (4) 12-month option periods, with an expected base year start of September 30, 2026. Services may be required 24/7 for emergent cases.
- Set-Aside: None specified; market research is being conducted to determine if a small business set-aside is appropriate. Small businesses are highly encouraged to respond.
- Response Due: May 22, 2026, 10:00 am CST.
- Questions Due: May 11, 2026, 10:00 pm CST.
- Published Date: April 30, 2026.
Response Requirements
Interested offerors must provide:
- Company contact information, business size (Small, SDB, HUBZone, 8A), and SAM Unique Entity Identification Number.
- Confirmation of NAICS code 325412 compliance.
- Indication of whether the company manufactures the product or is an authorized distributor/reseller.
- Proof of licensing for any compounding pharmacy and USNRC/State licensing for radioactive materials.
- Information on Buy American/Trade Agreement Certificates in SAM, product country of origin, and delivery schedules.
- Details on product availability under GWAC, GSA, IDIQ, or BPA contracts.
- Descriptive literature for equivalent products and a list of relevant contracts.
- Estimated industry pricing for market research and budgetary purposes.
Additional Notes
This notice is for market research only and does not constitute a Request for Proposal (RFP), Invitation for Bid (IFB), or Request for Quotation (RFQ). The Government is not obligated to enter into a contract based on responses.